{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:46:01Z","timestamp":1791549961224,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"am","delay-in-days":305,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009412","name":"USC Alfred E Mann School of Pharmacy and Pharmaceutical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009020","name":"University of South China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009020","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30 DK048522"],"award-info":[{"award-number":["P30 DK048522"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.metabol.2024.155942","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T18:01:22Z","timestamp":1718215282000},"page":"155942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["The mitochondrial TSPO ligand Atriol mitigates metabolic-associated steatohepatitis by downregulating CXCL1"],"prefix":"10.1016","volume":"159","author":[{"given":"Yuchang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Sottas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahima Chandrakant","family":"Raul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nrupa Dinesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janaki Ramulu","family":"Bijja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Kaleem","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Kapelanski-Lamoureux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthoula","family":"Lazaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Metrakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zambidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shefali","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Sugahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"748\u2013755","key":"10.1016\/j.metabol.2024.155942_bb0005","article-title":"Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2024.155942_bb0010","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/gutjnl-2017-315691","article-title":"Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation","volume":"67","author":"Ibrahim","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2024.155942_bb0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of Resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2024.155942_bb0020","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2024.155942_bb0025","article-title":"New targets for NAFLD","volume":"3","author":"Parlati","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.metabol.2024.155942_bb0030","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2024.155942_bb0035","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa2304286","article-title":"Randomized, controlled trial of the FGF21 analogue Pegozafermin in NASH","volume":"389","author":"Loomba","year":"2023","journal-title":"N Engl J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.metabol.2024.155942_bb0040","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/2047-783X-15-S2-120","article-title":"Proinflammatory cytokines Il-6 and TNF-alpha and the development of inflammation in obese subjects","volume":"15","author":"Popko","year":"2010","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.metabol.2024.155942_bb0045","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-kappaB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.metabol.2024.155942_bb0050","doi-asserted-by":"crossref","first-page":"32048","DOI":"10.1074\/jbc.274.45.32048","article-title":"Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1","volume":"274","author":"Delerive","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2024.155942_bb0055","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.22519","article-title":"Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response","volume":"48","author":"Wang","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.155942_bb0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nri3399","article-title":"Neutrophil recruitment and function in health and inflammation","volume":"13","author":"Kolaczkowska","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.metabol.2024.155942_bb0065","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.171.5.1797","article-title":"Neutrophil-activating properties of the melanoma growth-stimulatory activity","volume":"171","author":"Moser","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.metabol.2024.155942_bb0070","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/hep.510250322","article-title":"Adenovirus-mediated expression of cytokine-induced neutrophil chemoattractant in rat liver induces a neutrophilic hepatitis","volume":"25","author":"Maher","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.155942_bb0075","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/hep.31031","article-title":"Interleukin-22 ameliorates neutrophil-driven nonalcoholic steatohepatitis through multiple targets","volume":"72","author":"Hwang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.155942_bb0080","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0168-8278(03)00460-4","article-title":"Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice","volume":"39","author":"Feldstein","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2024.155942_bb0085","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2353\/ajpath.2009.080999","article-title":"Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis","volume":"175","author":"Rensen","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.metabol.2024.155942_bb0090","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep4.1566","article-title":"Therapeutic targeting of myeloperoxidase attenuates NASH in mice","volume":"4","author":"Koop","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.metabol.2024.155942_bb0095","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1089\/ars.2014.6108","article-title":"Myeloperoxidase-hepatocyte-stellate cell cross talk promotes hepatocyte injury and fibrosis in experimental nonalcoholic steatohepatitis","volume":"23","author":"Pulli","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.metabol.2024.155942_bb0100","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.tips.2006.06.005","article-title":"Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function","volume":"27","author":"Papadopoulos","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.metabol.2024.155942_bb0105","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nrd3295","article-title":"Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders","volume":"9","author":"Rupprecht","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.metabol.2024.155942_bb0110","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jhep.2012.07.002","article-title":"Translocator protein (18 kDa), a potential molecular imaging biomarker for non-invasively distinguishing non-alcoholic fatty liver disease","volume":"57","author":"Xie","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2024.155942_bb0115","article-title":"Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver disease","volume":"24","author":"Li","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.metabol.2024.155942_bb0120","article-title":"Mitochondrial translocator protein (TSPO, 18kDa): a key multifunctional molecule in liver diseases","author":"Li","year":"2023","journal-title":"Biochimie"},{"key":"10.1016\/j.metabol.2024.155942_bb0125","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/jcbfm.2009.205","article-title":"Evaluation of the PBR\/TSPO radioligand [(18)F]DPA-714 in a rat model of focal cerebral ischemia","volume":"30","author":"Martin","year":"2010","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.metabol.2024.155942_bb0130","doi-asserted-by":"crossref","DOI":"10.1177\/1536012119871455","article-title":"PET\/SPECT molecular probes for the diagnosis and staging of nonalcoholic fatty liver disease","volume":"18","author":"Shao","year":"2019","journal-title":"Mol Imaging"},{"key":"10.1016\/j.metabol.2024.155942_bb0135","doi-asserted-by":"crossref","first-page":"9875","DOI":"10.1074\/jbc.M110.203216","article-title":"Novel androstenetriol interacts with the mitochondrial translocator protein and controls steroidogenesis","volume":"286","author":"Midzak","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2024.155942_bb0140","doi-asserted-by":"crossref","first-page":"nzaa078","DOI":"10.1093\/cdn\/nzaa078","article-title":"Targeted nutrient modifications in purified diets differentially affect nonalcoholic fatty liver disease and metabolic disease development in rodent models","volume":"4","author":"Radhakrishnan","year":"2020","journal-title":"Curr Dev Nutr"},{"key":"10.1016\/j.metabol.2024.155942_bb0145","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Martinez Molina","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.metabol.2024.155942_bb0150","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat Protoc"},{"key":"10.1016\/j.metabol.2024.155942_bb0155","doi-asserted-by":"crossref","first-page":"8157","DOI":"10.1038\/s41598-018-26383-8","article-title":"Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis","volume":"8","author":"Goto","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2024.155942_bb0160","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2024.155942_bb0165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/asj.12392","article-title":"Role of peroxisome proliferator-activated receptor alpha in the expression of hepatic fatty acid oxidation-related genes in chickens","volume":"87","author":"Honda","year":"2016","journal-title":"Anim Sci J"},{"key":"10.1016\/j.metabol.2024.155942_bb0170","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mce.2010.05.019","article-title":"Peroxisome proliferator activated receptor alpha (PPARalpha) and PPAR gamma coactivator (PGC-1alpha) induce carnitine palmitoyltransferase IA (CPT-1A) via independent gene elements","volume":"325","author":"Song","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.metabol.2024.155942_bb0175","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2009.11.030","article-title":"Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model","volume":"52","author":"Rector","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2024.155942_bb0180","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.redox.2014.09.006","article-title":"Proteomic analysis of 4-hydroxynonenal (4-HNE) modified proteins in liver mitochondria from chronic ethanol-fed rats","volume":"2","author":"Andringa","year":"2014","journal-title":"Redox Biol"},{"key":"10.1016\/j.metabol.2024.155942_bb0185","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1194\/jlr.R066597","article-title":"Oxidative stress and lipotoxicity","volume":"57","author":"Hauck","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2024.155942_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013577","article-title":"Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients","volume":"5","author":"Bertola","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.metabol.2024.155942_bb0195","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/hep.27921","article-title":"Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1","volume":"62","author":"Chang","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.155942_bb0200","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1148\/radiol.2017164044","article-title":"Myeloperoxidase nuclear imaging for epileptogenesis","volume":"282","author":"Zhang","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.metabol.2024.155942_bb0205","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/jcbfm.2014.222","article-title":"Myeloperoxidase propagates damage and is a potential therapeutic target for subacute stroke","volume":"35","author":"Forghani","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.metabol.2024.155942_bb0210","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1172\/JCI110652","article-title":"Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation","volume":"70","author":"Weiss","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2024.155942_bb0215","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2024.155942_bb0220","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1152\/ajpendo.00347.2013","article-title":"NF-kappaB and STAT1 control CXCL1 and CXCL2 gene transcription","volume":"306","author":"Burke","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2024.155942_bb0225","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4049\/jimmunol.147.2.520","article-title":"An NF-kappa B-like transcription factor mediates IL-1\/TNF-alpha induction of gro in human fibroblasts","volume":"147","author":"Anisowicz","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.metabol.2024.155942_bb0230","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1093\/nar\/23.20.4210","article-title":"HMGI(Y) and Sp1 in addition to NF-kappa B regulate transcription of the MGSA\/GRO alpha gene","volume":"23","author":"Wood","year":"1995","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.metabol.2024.155942_bb0235","first-page":"1372","article-title":"Elevated constitutive IkappaB kinase activity and IkappaB-alpha phosphorylation in Hs294T melanoma cells lead to increased basal MGSA\/GRO-alpha transcription","volume":"59","author":"Devalaraja","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.metabol.2024.155942_bb0240","doi-asserted-by":"crossref","first-page":"15952","DOI":"10.18632\/oncotarget.24640","article-title":"Uev1A-Ubc13 promotes colorectal cancer metastasis through regulating CXCL1 expression via NF-small ka, CyrillicB activation","volume":"9","author":"Wu","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.metabol.2024.155942_bb0245","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.devcel.2021.03.034","article-title":"Lipid metabolism and lipid signals in aging and longevity","volume":"56","author":"Mutlu","year":"2021","journal-title":"Dev Cell"},{"key":"10.1016\/j.metabol.2024.155942_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021243","article-title":"The role of myeloperoxidase in clozapine-induced inflammation: a mechanistic update for idiosyncratic drug-induced agranulocytosis","volume":"24","author":"Sernoskie","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049524001690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049524001690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T15:19:20Z","timestamp":1728055160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049524001690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":50,"alternative-id":["S0026049524001690"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2024.155942","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mitochondrial TSPO ligand Atriol mitigates metabolic-associated steatohepatitis by downregulating CXCL1","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2024.155942","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155942"}}